371 related articles for article (PubMed ID: 25165114)
1. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
[TBL] [Abstract][Full Text] [Related]
2. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.
Buggert M; Norström MM; Czarnecki C; Tupin E; Luo M; Gyllensten K; Sönnerborg A; Lundegaard C; Lund O; Nielsen M; Karlsson AC
PLoS One; 2012; 7(7):e39874. PubMed ID: 22792193
[TBL] [Abstract][Full Text] [Related]
3. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
[TBL] [Abstract][Full Text] [Related]
5. Contribution of proteasome-catalyzed peptide
Paes W; Leonov G; Partridge T; Chikata T; Murakoshi H; Frangou A; Brackenridge S; Nicastri A; Smith AG; Learn GH; Li Y; Parker R; Oka S; Pellegrino P; Williams I; Haynes BF; McMichael AJ; Shaw GM; Hahn BH; Takiguchi M; Ternette N; Borrow P
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24748-24759. PubMed ID: 31748275
[TBL] [Abstract][Full Text] [Related]
6. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
7. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
8. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
9. Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.
Ternette N; Block PD; Sánchez-Bernabéu Á; Borthwick N; Pappalardo E; Abdul-Jawad S; Ondondo B; Charles PD; Dorrell L; Kessler BM; Hanke T
J Virol; 2015 Jun; 89(11):5760-71. PubMed ID: 25810538
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 variation diminishes CD4 T lymphocyte recognition.
Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
Becker Y
Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
[TBL] [Abstract][Full Text] [Related]
13. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
Weidanz JA; Piazza P; Hickman-Miller H; Woodburn D; Nguyen T; Wahl A; Neethling F; Chiriva-Internati M; Rinaldo CR; Hildebrand WH
J Immunol Methods; 2007 Jan; 318(1-2):47-58. PubMed ID: 17134715
[TBL] [Abstract][Full Text] [Related]
14. Human immune responses to porcine endogenous retrovirus-derived peptides presented naturally in the context of porcine and human major histocompatibility complex class I molecules: implications in xenotransplantation of porcine organs.
Ramachandran S; Jaramillo A; Xu XC; McKane BW; Chapman WC; Mohanakumar T
Transplantation; 2004 May; 77(10):1580-8. PubMed ID: 15239626
[TBL] [Abstract][Full Text] [Related]
15. HLA class I molecules consistently present internal influenza epitopes.
Wahl A; Schafer F; Bardet W; Buchli R; Air GM; Hildebrand WH
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):540-5. PubMed ID: 19122146
[TBL] [Abstract][Full Text] [Related]
16. Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
Ternette N; Yang H; Partridge T; Llano A; Cedeño S; Fischer R; Charles PD; Dudek NL; Mothe B; Crespo M; Fischer WM; Korber BT; Nielsen M; Borrow P; Purcell AW; Brander C; Dorrell L; Kessler BM; Hanke T
Eur J Immunol; 2016 Jan; 46(1):60-9. PubMed ID: 26467324
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
18. Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands.
Nicholas B; Bailey A; Staples KJ; Wilkinson T; Elliott T; Skipp P
PLoS Pathog; 2022 Jan; 18(1):e1009894. PubMed ID: 35051231
[TBL] [Abstract][Full Text] [Related]
19. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.
Berger CT; Carlson JM; Brumme CJ; Hartman KL; Brumme ZL; Henry LM; Rosato PC; Piechocka-Trocha A; Brockman MA; Harrigan PR; Heckerman D; Kaufmann DE; Brander C
J Exp Med; 2010 Jan; 207(1):61-75. PubMed ID: 20065065
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
